Discriminant Ability of the Shock Index, Modified Shock Index, and Reverse Shock Index Multiplied by the Glasgow Coma Scale on Mortality in Adult Trauma Patients: A PATOS Study

Sponsor
Mackay Memorial Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT05549986
Collaborator
(none)
105,641
60

Study Details

Study Description

Brief Summary

We evaluated a cohort of adult trauma patients transported to emergency departments. The first vital signs were used to calculate the SI, MSI, and rSIG. The areas under the receiver operating characteristic curves (AUROCs) and test results were used to compare the discriminant performance of the indices on short-term mortality and poor functional outcome. A subgroup analysis of geriatric patients, traumatic brain injury, penetrating injury, and non-penetrating injury was performed.

Condition or Disease Intervention/Treatment Phase
  • Other: Observational

Study Design

Study Type:
Observational
Actual Enrollment :
105641 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Discriminant Ability of the Shock Index, Modified Shock Index, and Reverse Shock Index Multiplied by the Glasgow Coma Scale on Mortality in Adult Trauma Patients: A PATOS Study
Actual Study Start Date :
Jan 1, 2016
Actual Primary Completion Date :
Dec 31, 2020
Actual Study Completion Date :
Dec 31, 2020

Arms and Interventions

Arm Intervention/Treatment
Mortality group

Patients encountered in-hospital mortality or 30-day mortality

Other: Observational
Observational

Survival group

Patients did not encounter in-hospital mortality or 30-day mortality

Other: Observational
Observational

Outcome Measures

Primary Outcome Measures

  1. Discriminant power of SI, MSI, and rSIG on short-term mortality for adult traumatic patients [30 days]

    AUROC in associated with short-term mortality with SI, MSI, rSIG

Secondary Outcome Measures

  1. Discriminant power of SI, MSI, and rSIG on functional outcome for adult traumatic patients [We defined no symptoms, no significant disability, slight disability, and moderate disability (MRS 0-3) as favorable functional outcomes and moderately severe disability, severe disability, and death (MRS 4-6) as poor functional outcomes]

    AUROC in associated with functional outcome with SI, MSI, rSIG

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Adult patients (≥18 years) EMS-transported from January 2016 to December 2020
Exclusion Criteria:
  • Patients with missing entries of age, sex, triage, SBP, DBP, HR, or GCS were excluded.

  • Entries with missing records of in-hospital mortality or 30-day mortality were excluded from the short-term mortality cohort analyses.

  • Patients without a Modified Rankin Scale (MRS) record at discharge were excluded from the functional outcome cohort analyses.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Mackay Memorial Hospital

Investigators

  • Principal Investigator: Tse-Hao Chen, M.D., Mackay Memorial Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Tse-Hao Chen, Principal Investigator, Mackay Memorial Hospital
ClinicalTrials.gov Identifier:
NCT05549986
Other Study ID Numbers:
  • 21MMHIS389e
First Posted:
Sep 22, 2022
Last Update Posted:
Sep 22, 2022
Last Verified:
Sep 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Tse-Hao Chen, Principal Investigator, Mackay Memorial Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 22, 2022